Literature DB >> 15539936

Genome-wide analysis of STAT target genes: elucidating the mechanism of STAT-mediated oncogenesis.

James V Alvarez1, David A Frank.   

Abstract

Inappropriate activation of transcription factors is a common event in cancer. These transcription factors contribute to a malignant phenotype by regulating genes involved in cellular proliferation, survival, differentiation, angiogenesis, and invasion. An important goal remains identifying the targets of oncogenic transcription factors that execute these changes. STAT proteins are among the best-studied of these transcription factors, and are involved in oncogenesis both in vivo and in vitro. They thus represent an ideal model for understanding how transcription factors cause cancer through coordinated changes in gene expression. Recent studies have employed microarray-based expression analysis to comprehensively identify STAT target genes. Analysis of these targets can provide insight into mechanisms of neoplastic transformation, and may shed light on new strategies for targeted therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539936     DOI: 10.4161/cbt.3.11.1172

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  40 in total

1.  Dysregulation of janus kinases and signal transducers and activators of transcription in cancer.

Authors:  Ana P Costa-Pereira; Nair A Bonito; Michael J Seckl
Journal:  Am J Cancer Res       Date:  2011-06-22       Impact factor: 6.166

2.  Transcriptional impact of Aire varies with cell type.

Authors:  Mireia Guerau-de-Arellano; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

Review 3.  The molecular details of cytokine signaling via the JAK/STAT pathway.

Authors:  Rhiannon Morris; Nadia J Kershaw; Jeffrey J Babon
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

4.  STAT3 Inhibition by Microtubule-Targeted Drugs: Dual Molecular Effects of Chemotherapeutic Agents.

Authors:  Sarah R Walker; Mousumi Chaudhury; David A Frank
Journal:  Mol Cell Pharmacol       Date:  2011-01-01

Review 5.  Stat3: friend or foe in colitis and colitis-associated cancer?

Authors:  Jie Han; Arianne L Theiss
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 6.  STAT3 in the systemic inflammation of cancer cachexia.

Authors:  Teresa A Zimmers; Melissa L Fishel; Andrea Bonetto
Journal:  Semin Cell Dev Biol       Date:  2016-02-06       Impact factor: 7.727

7.  MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis.

Authors:  Georgios Koukos; Christos Polytarchou; Jess L Kaplan; Alessio Morley-Fletcher; Beatriz Gras-Miralles; Efi Kokkotou; Mariah Baril-Dore; Charalabos Pothoulakis; Harland S Winter; Dimitrios Iliopoulos
Journal:  Gastroenterology       Date:  2013-07-12       Impact factor: 22.682

8.  Enabling Combinatorial siRNA Delivery against Apoptosis-Related Proteins with Linoleic Acid and α-Linoleic Acid Substituted Low Molecular Weight Polyethylenimines.

Authors:  Samarwadee Plianwong; Bindu Thapa; Remant Bahadur Kc; Cezary Kucharski; Theerasak Rojanarata; Hasan Uludağ
Journal:  Pharm Res       Date:  2020-02-03       Impact factor: 4.200

9.  Turn down genes for WAT? Activation of anti-apoptosis pathways protects white adipose tissue in metabolically depressed thirteen-lined ground squirrels.

Authors:  Samantha M Logan; Bryan E Luu; Kenneth B Storey
Journal:  Mol Cell Biochem       Date:  2016-03-31       Impact factor: 3.396

10.  Avicin D: a protein reactive plant isoprenoid dephosphorylates Stat 3 by regulating both kinase and phosphatase activities.

Authors:  Valsala Haridas; Goshi Nishimura; Zhi-Xiang Xu; Fiona Connolly; Margaret Hanausek; Zbigniew Walaszek; Robert Zoltaszek; Jordan U Gutterman
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.